Originally published by our sister publication Gastroenterology & Endoscopy News
By Caroline Helwick
WASHINGTON—Evidence is emerging for the power of fecal immunochemical testing to not only reduce colorectal cancer incidence but also deaths related to the disease. The latest comes from a study presented of enrollees in two Kaiser Permanente health systems in California for whom completion of FIT within a mailed outreach screening program yielded a mortality benefit across all